Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
Clinical trial NCT03245151 · COMPLETED
Trial details
- NCT number
- NCT03245151
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-16
- Primary completion
- 2022-09-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.